BB Biotech AG
BBAGF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.94B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.94 Billion |
|---|---|
| Enterprise Value | $4.74 Billion |
| Annual dividend | $2.78 |
| Dividend yield | 4.39% |
| Earnings per Share | $10.56 |
| Beta | 0.6 |
| Outstanding Shares | 65,975,047 |
Return
| Return on Equity | 34.90% |
|---|---|
| Return on Assets | 34.84% |
| Return on Invested Capital | 34.84% |
Valuation & Multiples
| P/E Ratio | 2.63 |
|---|---|
| PEG | -4.32 |
| Price to Sales | 21.45 |
| Price to Book Ratio | 1.4 |
| Enterprise Value to Revenue | 21.59 |
| Enterprise Value to EBIT | 4.4 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 23, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
January 22, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BB Biotech AG
10 employees
CEO: Daniel Koller
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of ...